#USA #New York #Gross Law Firm #BHVN #Biohaven Ltd.

Important Notice for Biohaven Ltd. Shareholders

In a recent announcement, The Gross Law Firm has reached out to shareholders of Biohaven Ltd. (NYSE: BHVN) concerning serious allegations raised during a designated class period. Shareholders who bought shares of BHVN between March 24, 2023, and May 14, 2025, are strongly encouraged to connect with the firm to discuss their rights and possible claims.

The Deadline
The deadline for shareholders to express interest and potentially be appointed as lead plaintiffs is September 12, 2025. Being appointed as a lead plaintiff is not a prerequisite for participation in the recovery process. Shareholders striving to understand their rights in the face of these allegations must act without delay.

Allegations Against Biohaven Ltd.

The allegations raised against Biohaven involve crucial misstatements and omissions concerning the company’s product candidate, troriluzole. It has been set forth that during the reported class period, the defendants made materially false and misleading statements. Specifically, it is claimed that:
1. The regulatory prospects of troriluzole as a treatment for SCA (Spinocerebellar Ataxia) were overstated.
2. The data that Biohaven presented to support the product's regulatory approval was likely insufficient.
3. Additionally, the efficacy and clinical prospects of BHV-7000 for treating bipolar disorder were also overstated.
4. When these realities emerged, they significantly impacted Biohaven's financial standing and business prospects, rendering the previous public statements misleading.

Next Steps for Shareholders

Shareholders who have purchased BHVN stock during the specified timeframe are urged to register their information as soon as possible. Upon registration, you will gain access to a portfolio monitoring tool that will keep you updated on the case's developments and provide pertinent information throughout the litigation process. Notably, joining this class action incurs no costs or obligations for participants.

Why Choose The Gross Law Firm?

The Gross Law Firm is recognized nationally for its commitment to defending investors' rights. The firm's mission revolves around ensuring that investors who have suffered losses due to deceit, fraud, and unethical business practices can seek proper recovery. The firm stands firm in its advocacy for good corporate citizenship and responsible business operations.

If you believe your investment in Biohaven Ltd. has been compromised due to false or misleading statements, now is the time to take action. Don’t miss the opportunity to secure your voice and rights as a shareholder. For more information, you can visit The Gross Law Firm's biohaven submission page.

Contact Information

For additional inquiries, you can reach The Gross Law Firm at:
Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Make sure to take the necessary steps before the deadline to protect your investment and ensure your voice is heard.